Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,484 total articles
PepsiCo's mix of scale, steady free cash flow ($8.84B), and an expanding healthier-premium snack portfolio makes it a pragmatic swing trade as the market prizes 'permissible snacking'. Valuation is reasonable (P/E ~23.3, EV/EBITDA ~14.0) and the stock yields ~3.8%. Trade plan: enter $151.50, stop $146.00, target $162.00 over ~45 trading days.
Tesla keeps refusing to collapse. Multiple durable demand drivers, improving services revenue and margin optionality make a tactical long reasonable today. This trade targets a measured move higher while respecting volatility through a disciplined stop.
Carter Bankshares (CARE) just checked a major box by resolving a non-performing loan tied to Justice Entities. With market cap near $581M, TTM EPS roughly $1.41 and a P/B around 1.38, the stock looks reasonably priced. This trade idea outlines an actionable long with entry, stop and target for a 45-trading-day horizon while weighing catalysts and r…
Hafnia is trading above key moving averages, offers a near-6% yield and sits on a market cap of roughly $4.41B. Technicals show recent strength, fundamentals show a profitable shipping operator, and corporate moves (TORM share sales) add optionality. This is a mid-term swing long idea: enter at $8.86, stop $8.00, target $10.50 (45 trading days).
Seagate shares have been slammed on headline volatility despite clear demand tailwinds from AI data centers. Fundamentals show strong cash generation, high margins, and constrained supply dynamics that justify a tactical long. This trade plan uses a disciplined entry at $703.10 with a $620 stop and $820 target over a mid-term 45 trading day horizon…
ImmunityBio (IBRX) just strengthened its bladder-cancer play with an exclusive U.S. deal for Tokyo-172 BCG and five U.S. patents for its ANKTIVA plus BCG platform through 2035. At a market cap near $7.76 billion and an enterprise value around $8.58 billion, the stock already prices in major success. The trade: a speculative long entry at $7.40 targ…
Lilly is no one-product story. With blockbuster GLP-1 cash flows supporting a deep pipeline (retatrutide, oral GLP-1 Foundayo) and meaningful free cash flow, LLY has the balance sheet and execution runway to push higher. This trade idea targets a measured long with a clear stop, leaning into continued momentum while respecting valuation.
PayPal trades at a mid-single-digit multiple of earnings with strong free cash flow, improving Venmo traction and a management reset underway. This is a tactical long: enter near $44.75, stop at $38.60, target $70 over a multi-month holding period. The trade profits if execution and margin stabilization follow through; it loses if competition and s…
Rocket Lab is executing — revenue growth, margin expansion and defense contracts are real. That said, the stock is trading at a sky-high multiple, momentum and hype around SpaceX are making the name crowded, and short-term upside appears priced in. This trade idea: a defined short with clear entry, stop and target over a mid-term (45 trading days) …
AppLovin (APP) is a rare adtech compounder showing large-scale revenue growth and exceptional profitability. With Q1 revenue of $1.84B (59% YoY), EBITDA margins expanding above 80%, and accelerating ad share gains versus larger peers, the company can justify a re-rating. This trade idea lays out an entry at $495.00, a stop at $420.00 and a long-ter…
Dutch Bros (BROS) reported strong comp growth and raised guidance, yet the stock slipped on elevated valuation. The business is expanding aggressively with attractive unit economics and healthy cash flow. We propose a tactical long: entry $53.40, stop $47.00, target $68.00, horizon 180 trading days. Risk is real — high P/E and macro pressure — but …
Oneok (OKE) trades at $93.90 and yields ~4.4% with a history of steady distributions and a recent beat-and-raise tone to guidance. With a reasonable 16.7x P/E, EV/EBITDA of 12.5 and $2.24B in free cash flow, this trade targets $112.70 over a long-term window (180 trading days) with a stop at $84.00. The risk profile is medium — interest-rate sensit…
Nu Holdings (NU) plunged after Q1 headlines focused on margins and near-term spending, but the business continues to grow rapidly — $5.32B revenue in Q1 and 135M customers. The selloff has pushed technicals into deep-oversold territory and trimmed valuation to a mid-teens P/E. This is a tactical long for traders willing to accept execution and macr…
Nebius (NBIS) delivered spectacular top-line growth in Q1 2026, but the stock now carries a premium that leaves little room for execution or macro disappointment. For traders worried about rate volatility, margin normalization or contract slippage, a short on NBIS around $199.85 with a $150 target (mid-term) is a tactical way to express a view that…
Berkshire Hathaway trades at roughly $1.05 trillion market cap with a P/E near 15, a rock-solid balance sheet and a $397.4 billion cash war chest. With new CEO Greg Abel accelerating buybacks and reallocating capital into high-conviction positions like Alphabet, the company can generate shareholder returns even without Warren Buffett at the helm. T…
Mammoth Energy Services (TUSK) trades like a deeply discounted oilfield-services operator. Market cap sits near $153M while enterprise value is roughly $61M, signaling meaningful net cash or asset value relative to equity. With a P/B around 0.58 and a forward-ish P/E near mid-teens, the stock looks cheap versus replacement-value logic. This trade i…
Topicus has been punished by investor impatience after a string of integration and growth hiccups. We view the current setup as a tactical long: the business still owns durable vertical SaaS assets, free-cash-generation potential and visible margin leverage. This trade pairs a disciplined entry with a tight stop and a clear target to capture a mult…
Pacira (PCRX) remains a viable tactical long. Exparel's growing real-world evidence for cost savings and continued revenue beats, combined with a roughly 15% free cash flow yield and modest valuation metrics (P/S ~1.2, EV/EBITDA ~9.6), support a mid-term rebound. I lay out an entry, stop and target for a mid-term trade and the key catalysts and ris…
Federal Agricultural Mortgage Corporation (AGM) looks attractively valued on P/E and P/B with a double-digit return on equity and a 4.7% yield. The trade: a mid-term (45 trading days) long to capture valuation re-rating and the June dividend, sized with a firm stop to limit exposure to rising agricultural credit stress and funding volatility.
Vertiv is the physical infrastructure provider sitting under the AI compute stack. A $15 billion backlog, 30%+ liquid-cooling margins, and double-digit organic growth justify optimism. But the shares trade like a high-growth software name: market cap near $130.5B and P/E around 84 demand execution. This trade targets continued AI-driven demand whil…
Amphenol's diversified interconnect and sensor franchises sit squarely in secular growth markets—data centers, telecom, and automotive. After a sharp post-earnings drop, the stock offers a mid-term buying opportunity: steady cash generation, high margins, and manageable leverage argue for upside while integration and cyclicality remain the primary …
FormFactor plunged after a recent investor event despite beating Q1 expectations and raising guidance. The combination of low leverage, expanding silicon-photonics capability, and a still-hot AI testing market supports a long trade from current levels. This plan targets a move back toward the $150 area within 180 trading days with a disciplined sto…
Coca-Cola (KO) trades like a mature growth-and-income compounder: strong free cash flow, a durable global distribution moat and a reliable dividend. At $81.39 the stock demands a premium, but fundamentals and technicals support a measured long trade for investors who want upside plus income over the next 180 trading days.
AutoZone reports fiscal Q3 on 05/26/2026. Fundamentals and seasonality set up a beat-if-clean quarter; valuation is reasonable on cash flow but the stock already prices steady performance. This trade targets a post-earnings continuation into spring repair season with defined risk controls.
International Seaways (INSW) is a liquid way to play a potential recovery in crude/product tanker earnings driven by ton-mile dynamics, fleet renewal, and outsized shareholder distribution. The company trades at a market cap of $4.23B with an enterprise value of $4.67B, a modest reported debt load and a dividend yielding just over 5% — conditions t…
